Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure

NCT02235077 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Spironolactone
DRUG: Placebo

Sponsor

Duke University

Collaborators

[object Object]